Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	CASE_CONTROL	Chemotherapy	Drug	Race	TIMEPOINT	Tamoxyfen	Taxane
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	76952	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	85210	Peak area	Case	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	97671	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	99054	Peak area	Control	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	108854	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	120045	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	123545	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	124634	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	126320	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	127173	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	145399	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	145521	Peak area	Control	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	155252	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	156284	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	156965	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	157459	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	164294	Peak area	Control	Y	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	170426	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	172376	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	177941	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	179330	Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	186250	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	187859	Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	188445	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	195717	Peak area	Control	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	196586	Peak area	Control	Y	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	198065	Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	215550	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	218128	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	232234	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	257047	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	268134	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	381231	Peak area	Case	N	Exemestane	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	524131	Peak area	Case	N	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	528467	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	536110	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	552896	Peak area	Control	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	575235	Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	582771	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	586482	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	589285	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	650160	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	657774	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	705618	Peak area	Case	Y	Exemestane	Black	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	707190	Peak area	Case	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	711598	Peak area	Case	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	718187	Peak area	Control	Y	Exemestane	White	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	741162	Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	756100	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	765682	Peak area	Control	N	Letrozole	Black	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	817915	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	825585	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	860068	Peak area	Control	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	888464	Peak area	Control	Y	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	918980	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	923626	Peak area	Control	Y	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	926501	Peak area	Control	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	950534	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	960571	Peak area	Control	Y	Exemestane	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	972660	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	991796	Peak area	Case	Y	Exemestane	Black	Baseline	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1020517	Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1037368	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1042134	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1061766	Peak area	Control	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1063541	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1092243	Peak area	Case	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1116265	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1135030	Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1138286	Peak area	Control	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1159790	Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1166608	Peak area	Control	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1169306	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1191324	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1205895	Peak area	Case	N	Exemestane	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1210206	Peak area	Case	Y	Letrozole	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1230316	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1320325	Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1332083	Peak area	Control	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1345327	Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1404452	Peak area	Control	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1450681	Peak area	Case	Y	Exemestane	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1503243	Peak area	Case	Y	Exemestane	White	3 Month	N	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1503286	Peak area	Control	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1608716	Peak area	Case	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1645617	Peak area	Control	N	Exemestane	Black	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+	1669567	Peak area	Case	Y	Letrozole	White	3 Month	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Letrozole	Black	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Letrozole	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	N	Letrozole	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Case	Y	Exemestane	White	Baseline	Y	Y
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Control	N	Exemestane	Black	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Control	N	Exemestane	White	3 Month	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Control	N	Letrozole	White	3 Month	Y	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Control	N	Letrozole	White	Baseline	N	N
Reversed phase POSITIVE ION MODE	MYO-INOSITOL (CAS# 87-89-8); (M+NA)+		Peak area	Control	Y	Letrozole	White	Baseline	Y	Y